Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide - Wikidata - wikimedia - TriplyDB

Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide

Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide

http://www.wikidata.org/entity/Q26865304

about

New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview.Defecating disorders: a common cause of constipation in women.New pharmacological treatment options for irritable bowel syndrome with constipation.Rare medical manifestations of severe restricting and purging: "Zebras," missed diagnoses, and best practices.Cellular mechanism for herbal medicine Junchoto to facilitate intestinal Cl-/water secretion that involves cAMP-dependent activation of CFTR.Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models.Plecanatide: a new guanylate cyclase agonist for the treatment of chronic idiopathic constipation.

P2860

Q26748617-9C22819B-23D7-437D-A285-2C8117AB8C1E Q35087100-6DE764F9-E54A-4086-9026-B4988F8A3165 Q35971357-2A6DD702-6947-4E06-A0A0-51E793A154F2 Q38559938-278D117E-9EBC-4DFF-BDD8-998AC41E2CFA Q38628078-33BECA26-E4BD-45FE-987E-D73A4E39D8FF Q38642691-F20A1CA0-6346-4759-953E-46A45F3ADB51 Q55185820-203B395C-961F-4E15-801C-48BFDFD68FAF Q55245208-C5800E07-98F4-4D8B-8CE6-7B2A01BC2C1A Q55259850-A6B69B50-94F0-4351-B56D-E9A06A270F15

P2860

Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide

http://www.wikidata.org/entity/Q26865304

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Advances in the management of ...... drome: the role of linaclotide

@ast

Advances in the management of ...... drome: the role of linaclotide

@en

Advances in the management of ...... drome: the role of linaclotide

@nl

type

label

Advances in the management of ...... drome: the role of linaclotide

@ast

Advances in the management of ...... drome: the role of linaclotide

@en

Advances in the management of ...... drome: the role of linaclotide

@nl

prefLabel

Advances in the management of ...... drome: the role of linaclotide

@ast

Advances in the management of ...... drome: the role of linaclotide

@en

Advances in the management of ...... drome: the role of linaclotide

@nl

P1433

Q26865304-305579CB-EE2D-43DF-8164-12C37AEC4BC5

P1476

Q26865304-98242963-3B2D-4A26-BA8F-E0B0B7F397FB

P2093

Q26865304-80009871-231C-46A9-BA92-B4D002E628A0

Q26865304-B4D11CDE-03DD-4DAA-A340-5E4CA8A140DD

P2860

Q26865304-06A17365-1937-4E71-AC44-2D67CBFC9610

Q26865304-09E0DFF8-5677-4BF6-A73A-04787B9DC9BC

Q26865304-0F3AE43B-A937-427C-9D0F-282706623753

Q26865304-10169016-1A8A-4CE5-880E-C2AB0B0954B8

Q26865304-10FAE67E-4862-4691-ACD1-685324B46967

Q26865304-1134A9F0-4124-4885-8562-CB3154791D0D

Q26865304-17FBA678-F9CF-4398-AB22-51CA23D3E2BD

Q26865304-1EF1DFFF-E0DC-48D8-88F3-F01D754CF6B2

Q26865304-1F17FCDB-FDCA-4CFC-97B7-BD3257E46FF8

Q26865304-1F4A376F-7C34-4948-A226-93FEABC373C6

P304

Q26865304-16E0C65A-A60A-4FD1-8B7E-B7E56A3D8755

P31

Q26865304-AAC0DDA1-A6C2-4711-8B8C-39AE72332A13

P356

Q26865304-179A7633-57DA-4ABC-8F26-BDAE17AF642D

P407

Q26865304-2A13F1C4-6E60-4A0F-AF08-0C95105E2DDC

P433

Q26865304-3BA9243B-8012-4A08-980B-1E9D2C55FE34

P478

Q26865304-E3ACE976-DA32-4D13-A4AC-FAA5F28D62FC

P577

Q26865304-AD9248D5-7E5A-42E8-B0DD-6D1A25D74D5E

P698

Q26865304-2C1EA6A1-3F15-4E7F-8BFA-17075E767738

P932

Q26865304-B84FCED2-EBE1-4F8C-BD5E-2908845C058C

P356

1756283X14537882

P1433

Therapeutic Advances in Gastroenterology

P1476

Advances in the management of ...... drome: the role of linaclotide

@en

P2093

S. S. C. Rao

http://www.w3.org/2001/XMLSchema#string

S. W. B. Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Functional bowel disorders

The current prevalence of irritable bowel syndrome in Asia

Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.

Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.

Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis.

Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat.

An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials.

Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study

Linaclotide - a secretagogue and antihyperalgesic agent - what next?

The epidemiology of irritable bowel syndrome in North America: a systematic review.

P304

193-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756283X14537882

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25177366

http://www.w3.org/2001/XMLSchema#string

P932

4107700

http://www.w3.org/2001/XMLSchema#string